Johnson & Johnson (FRA:JNJ)
178.06
-0.18 (-0.10%)
At close: Jan 9, 2026
Johnson & Johnson Employees
Johnson & Johnson had 138,100 employees as of December 29, 2024. The number of employees increased by 6,200 or 4.70% compared to the previous year.
Employees
138,100
Change (1Y)
6,200
Growth (1Y)
4.70%
Revenue / Employee
€570,643
Profits / Employee
€155,552
Market Cap
423.35B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 29, 2024 | 138,100 | 6,200 | 4.70% |
| Dec 31, 2023 | 131,900 | -20,800 | -13.62% |
| Jan 1, 2023 | 152,700 | 11,000 | 7.76% |
| Jan 2, 2022 | 141,700 | 7,200 | 5.35% |
| Jan 3, 2021 | 134,500 | 2,300 | 1.74% |
| Dec 29, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 3, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 317,562 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 98,995 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Johnson & Johnson News
- 12 hours ago - The 2026 Dogs Of The Dow: 10 High-Yield Blue Chips - Forbes
- 1 day ago - Johnson & Johnson Reports Durable Responses With RYBREVANT In Metastatic Colorectal Cancer - Nasdaq
- 1 day ago - RYBREVANT® (amivantamab-vmjw) longer-term results show promising and durable responses in difficult-to-treat colorectal cancer - PRNewsWire
- 1 day ago - January Dogs Of The Dow: One Ideal 'Safer' Dividend Buy - Seeking Alpha
- 2 days ago - Johnson & Johnson (JNJ) Target Price Raised by Bernstein to $208 | JNJ Stock News - GuruFocus
- 2 days ago - Johnson & Johnson announces drug pricing deal with Trump admin - The Hill
- 2 days ago - 2 Healthcare Stocks That Can Diversify a Tech-Heavy Portfolio - The Motley Fool
- 2 days ago - Johnson & Johnson (JNJ) Agrees to Price Cuts Amid Tariff Exemption Deal - GuruFocus